参考文献/References:
[1] Nakakuma K, Tashiro S, Hiraoka T, et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated hepatic artery for liver cancer [J]. Cancer, 1983, 52: 2193 - 2200.
[2] Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization imp-roves survival[J]. Hepatology, 2003, 37: 429 - 442.
[3] Cammà C, Schepis F, Orlando A, et al. Transarterial chemoem-bolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials[J]. Radiology, 2002, 224: 47 - 54.
[4] Maluccio MA, Covey AM, Porat LB, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma[J]. J Vasc Interv Radiol, 2008, 19: 862 - 869.
[5] Gomes AS, Rosove MH, Rosen PJ, et al. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients[J]. Am J Roentgenol, 2009, 193: 1665 - 1671.
[6] Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study[J]. Cardiovasc Intervent Radiol, 2010, 33: 41 - 52.
[7] 罗剑钧, 王建华, 刘清欣, 等. 微球联合碘油栓塞治疗肝癌的初步经验[J]. 介入放射学杂志, 2007, 16: 162 - 164.
[8] 赵广生, 杨晓红, 李 闯, 等. 新型明胶颗粒栓塞剂在肝癌介入治疗中的应用[J]. 中国新药杂志, 2010, 19: 1571 - 1574.
[9] Nakamura H, Tanaka T, Hori S, et al. Transcatheter emboliza-tion of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization[J]. Radiology, 1983, 147: 401 - 405.
[10] Sonomura T, Yamada R, Kishi K, et al. Dependency of tissue necrosis on gelatin sponge particle size after canine hepatic artery embolization[J]. Cardiovasc Intervent Radiol, 1997, 20: 50 - 53.
[11] Katsumori T, Kasahara T. The size of gelatin sponge particles: differences with preparation method[J]. Cardiovasc Intervent Radiol, 2006, 29: 1077 - 1083.
[12] Tabata Y, Ikada Y. Synthesis of gelatin microspheres containing interferon[J]. Pharm Res, 1989, 6: 422 - 427.
[13] Nitta N, Ohta S, Tanaka T, et al. Gelatin microspheres: Initial clinical experience for the transcatheter arterial embolization[J]. Eur J Radiol, 2008, 67: 536 - 540.
[14] Ohta S, Nitta N, Takahashi M, et al. Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model[J]. Korean J Radiol, 2007, 8: 418 - 428.
[15] Nitta N, Ohta S, Tanaka T, et al. An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors[J]. Eur J Radiol, 2009, 71: 519 - 526.
[16] Chung JW. Transcatheter arterial chemoembolization of hepatocel-lular carcinoma[J]. Hepatogastroenterology, 1998, 45(suppl 3): 1236 - 1241.
[17] Louail B, Sapoval M, Bonneau M, et al. A new porcine sponge material for temporary embolization: an experimental short-term pilot study in swine[J]. Cardiovasc Intervent Radiol, 2006, 29: 826 - 831.
[18] Geschwind JF, Ramsey DE, Cleffken B, et al. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency[J]. Cardiovasc Intervent Radiol, 2003, 26: 111 - 117.
[19] Raoul JL, Heresbach D, Bretagne JF, et al.Chemoembolization for hepatocellular carcinoma. A study of the biodistribution and pharmacokinetics of doxorubicin[J]. Cancer, 1992, 70: 585 - 590.
[20] Konishi M, Yasuhiko T, Masatoshi K, et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel[J]. J Control Release, 2005, 103: 7 - 19.
[21] Muvaffak A, Gurhan I, Gunduz U, et al. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate[J]. J Drug Target, 2005, 13: 151 - 159.
[22] Ohta S, Nitta N, Sonoda A, et al. Prolonged local persistence of cisplatin-loaded gelatin microspheres and their chemoembolic anti-cancer effect in rabbits[J]. Eur J Radiol, 2009, 72: 534 - 540.
[23] Ohta S, Nitta N, Sonoda A, et al. Cisplatin-conjugated degradable gelatin microspheres: fundamental study in vitro[J]. Br J Radiol, 2009, 82: 380 - 385.
[24] Ma Y, Wan Y, Luo DH, et al. Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit[J]. World J Gastroenterol, 2010, 16: 2120 - 2128.
[25] Takayasu K, Arii S, Ikai I, et al. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis[J]. AJR, 2010, 194: 830 - 837.
[26] Brown DB, Pilgram TK, Darcy MD, et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents[J]. J Vasc Interv Radiol, 2005, 16: 1661 - 1666.
[27] Makuuchi M, Sukigara M, Mori T, et al. Bile duct necrosis: complication of transcatheter hepatic arterial embolization[J]. Radiology, 1985, 156: 331 - 334.
相似文献/References:
[1].Spontaneous regression of a giant basilar artery aneurysm in a young adult after surgical injury ：case report and literature review[J].介入放射学杂志,2007,(10):718.
ZHANG He,LI Ming-hua,WANG Chun,et al.Spontaneous regression of a giant basilar artery aneurysm in a young adult after surgical injury ：case report and literature review[J].journal interventional radiology,2007,(12):718.
[2]李统怀,郑红枫. 子宫动脉栓塞治疗子宫瘢痕妊娠１１例[J].介入放射学杂志,2011,(11):898.
LI Tong-huai,ZHENG Hong-feng..Clinical application of uterine artery embolization in treating uterine scar pregnancy[J].journal interventional radiology,2011,(12):898.
[3]吕维富,张爱武,周春泽,等. 子宫动脉的三维DSA表现及其最佳显示体位探讨[J].介入放射学杂志,2011,(11):853.
LV Wei-fu,ZHANG Ai-wu,ZHOU Chun-ze,et al.3D-DSA findings of uterine artery and its optimal projection position[J].journal interventional radiology,2011,(12):853.
[4]张 靖,周少毅,陈昆山,等.经导管动脉硬化栓塞联合注射硬化治疗婴儿颌面部巨大高流量血管瘤[J].介入放射学杂志,2011,(11):848.
ZHANG Jing,ZHOU Shao-yi,CHEN Kun-shan,et al.Transcatheter arterial sclerosing embolization with injection sclerotherapy for the treatment of huge and high-flow maxillofacial hemangiomas in infants[J].journal interventional radiology,2011,(12):848.
[5]谢小西,吕银祥,章宏欣,等. 肝动脉化疗栓塞、射频消融联合１２５Ⅰ粒子植入 治疗原发性肝癌的临床应用[J].介入放射学杂志,2011,(11):863.
XIE Xiao-xi,LV Yin-xiang,ZHANG Hong-xin,et al.The clinical application of TACE together with RFA and 125Ⅰ seed implantation in treating hepatocellular carcinoma[J].journal interventional radiology,2011,(12):863.
[6]王铭义,王 峰. 脑灌注成像在颈动脉狭窄介入治疗中的应用[J].介入放射学杂志,2011,(11):915.
WANG Ming-yi,WANG Feng..Application of brain perfusion imaging in interventional treatment of carotid artery stenosis[J].journal interventional radiology,2011,(12):915.
[7]杜 猛,张锦生. 介入治疗急性深静脉血栓的临床观察[J].介入放射学杂志,2011,(11):858.
DU Meng,ZHANG Jing-sheng..Interventional therapy for acute deep venous thrombosis: a clinical observation[J].journal interventional radiology,2011,(12):858.
[8]孟庆娜,李国庆,白晓冬. 急性心肌梗死介入治疗术中恶心呕吐的护理[J].介入放射学杂志,2011,(11):913.
MENG Qing-na,LI Guo-qing,BAI Xiao-dong..The nursing care of nausea and vomiting occurred in interventional treatment for acute myocardial infarction[J].journal interventional radiology,2011,(12):913.
[9]王海亭,蒋忠仆,周 毅,等. 透视引导下鱼肝油酸钠泡沫硬化剂治疗下肢静脉曲张３０例[J].介入放射学杂志,2011,(11):905.
WANG Hai-ting,JIANG Zhong-pu,ZHOU Yi,et al.Fluoroscopically-guided foam sclerotherapy with sodium morrhuate for the treatment of lower extremity varices[J].journal interventional radiology,2011,(12):905.
[10]杜 鲲,管 生,胡小波,等. 原发性肝癌ＴＡＣＥ术后完全缓解病灶磁共振 ＡＤＣ值可重复性及一致性研究[J].介入放射学杂志,2011,(11):867.
DU Kun,GUAN Sheng,HU Xiao-bo,et al.Magnetic resonance apparent diffusion coefficient values of the completely remitted lesions of primary hepatocellular carcinoma after TACE: a study of their repeatability and consistency[J].journal interventional radiology,2011,(12):867.
[11]张 磊,陆骊工,李 勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(12):968.
[12]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(12):75.
[13]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(12):78.
[14]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(12):322.
[15]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
.Ｔｈｅ ｖｏｌｕｍｅ ｏｆ Ｌｉｐｉｏｄｏｌ ｕｓｅｄ ｉｎ ＴＡＣＥ： ｉｔｓ ｃｕｒｒｅｎｔ ｓｉｔｕａｔｉｏｎ ａｎｄ ｒｅｓｅａｒｃｈ ｐｒｏｇｒｅｓｓ [J].journal interventional radiology,2012,(12):348.
[16]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(12):682.
[17]冉 琳,任伯绪. 125I粒子组织间近距离放射治疗肝癌的现状与进展[J].介入放射学杂志,2012,(10):876.
RAN Lin,REN Bo- xu.. 125I radioactive seeds brachytherapy for hepatocellular carcinomas： its present situation and research progress[J].journal interventional radiology,2012,(12):876.
[18]罗中华,秦 勉,张学昕,等.原发性肝癌合并下腔静脉及右心房癌栓的动脉内化疗栓塞治疗[J].介入放射学杂志,2012,(12):1035.
LUO Zhong? hua,QIN Mian,ZHANG Xue? xin,et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma complicated by tumor thrombus in inferior vena cava and right atrium[J].journal interventional radiology,2012,(12):1035.
[19]徐光如,张明辉,朱红星,等.磁共振ADC值评价肝硬化合并肝癌介入治疗后肝功能储备的初步研究[J].介入放射学杂志,2013,(01):36.
XU Guang? ru,ZHANG Ming? hui,ZHU Hong? xing,et al. The application of MR?蛳 ADC value in evaluating the liver function reserve in patients with cirrhosis complicated by hepatic cancer after interventional treatment： a preliminary study[J].journal interventional radiology,2013,(12):36.
[20]徐 阳,臧 爽,陈路锋,等.Logistic回归及ROC曲线综合评价血生化指标对肝癌TACE术后发热的预测价值 [J].介入放射学杂志,2013,(06):513.
XU Yang,ZANG Shuang,CHEN Lu? feng,et al. Combination evaluation of plasma biochemical indexes with Logistic regression and ROC analysis in predicting hyperthermia after transcatheter hepatic arterial chemoembolization for liver cancer[J].journal interventional radiology,2013,(12):513.